Detalhe da pesquisa
1.
A global action agenda for turning the tide on fatty liver disease.
Hepatology
; 79(2): 502-523, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540183
2.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology
; 78(6): 1966-1986, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363821
3.
A global research priority agenda to advance public health responses to fatty liver disease.
J Hepatol
; 79(3): 618-634, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353401
4.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
J Hepatol
; 79(6): 1542-1556, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364790
5.
Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
J Viral Hepat
; 30(1): 56-63, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197907
6.
Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease.
Liver Int
; 43(6): 1225-1233, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026404
7.
Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective.
Ann Hepatol
; 27(2): 100673, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074476
8.
Position statement on the use of albumin in liver cirrhosis.
Ann Hepatol
; 27(4): 100708, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550187
9.
Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
Dig Dis Sci
; 66(12): 4501-4507, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428035
10.
An Integrated Review of the Hepatorenal Syndrome.
Ann Hepatol
; 22: 100236, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846202
11.
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).
Ann Hepatol
; 20: 100271, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099028
12.
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
Ann Hepatol
; 25: 100350, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864948
13.
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' .
Hepatology
; 79(2): E16-E17, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112434
14.
The impact of different infectious complications on mortality of hospitalized patients with liver cirrhosis.
Ann Hepatol
; 19(4): 427-436, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299682
15.
NRF-2 and nonalcoholic fatty liver disease.
Ann Hepatol
; 19(5): 458-465, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959521
16.
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.
Ann Hepatol
; 19(6): 674-690, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031970
17.
Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation.
Liver Transpl
; 22(3): 298-304, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26609794
18.
Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).
Ann Hepatol
; 22: 100326, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582320
19.
Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease.
Hepatology
; 69(4): 1838-1841, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30372535
20.
Diagnostic Accuracy of the Triglyceride-Glucose Index (TyG), TyG Body Mass Index, and TyG Waist Circumference Index for Liver Steatosis Detection.
Diagnostics (Basel)
; 14(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38611675